Cell-free technologies for biopharmaceutical research and production

Area of Science:

• Biotechnology
• Biopharmaceutical Manufacturing
• Protein Engineering

Background:

• Cell-free protein synthesis (CFPS) has transitioned from laboratory-scale applications to industrial biopharmaceutical production.
• CFPS is increasingly utilized in biopharmaceutical product discovery and development.
• Several CFPS-based products are currently undergoing human clinical trials.

Purpose of the Study:

• To highlight the advancements and expanding applications of CFPS technologies.
• To emphasize the role of CFPS in biopharmaceutical research and development.
• To showcase the potential of CFPS in creating novel biotherapeutics.

Main Methods:

• Leveraging the inherent flexibility and open nature of CFPS systems.
• Utilizing CFPS for the efficient incorporation of non-natural amino acids (nnAAs).
• Scaling CFPS processes for Good Manufacturing Practice (GMP) production.

Main Results:

• CFPS is now capable of biopharmaceutical production at the GMP manufacturing scale.
• CFPS facilitates the incorporation of nnAAs, expanding the repertoire of possible protein products.
• CFPS-based products are progressing through multiple human clinical trials.

Conclusions:

• CFPS technologies are a mature and scalable platform for biopharmaceutical production.
• The ability to incorporate nnAAs using CFPS significantly broadens the scope of potential biotherapeutics.
• CFPS is poised to drive significant advancements in the field of biotherapies.